Xenon Pharmaceuticals Inc.

Q2 2022 13F Holders

Symbol
XENE
CUSIP
98420N105
Type
Equity
Class
COM
Num filers
153
Total reported value, excl. options
$1.73B
Manager Report Date Value ($000) Shares